In this issue, we offer up a variety of perspectives on ways to improve, broaden, and deepen the business aspects of the clinical research enterprise for the benefit of all its stakeholders. Included are welcome contributions from Ireland and the European Union on some big-picture topics, and focused columns that bring us valuable glimpses into such specialized areas as patient recruitment and retention, data management, digital therapeutics, decentralized trials, dose optimization, and more.